On the whole, ghrelin and its receptors participate in the occurrence and development of the atherosclerotic process, and elevations of both levels may represent a compensatory mechanism to reverse the process, while, in kidney transplant patients and older people with MS or hypertension, this compensatory ability may be lost or damaged, of course, this deduction need further confirmation. The gene discussed is GHRL; the disease is hypertensive disorder.